UTI Healthcare Fund

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Growthvine rating: 4/5 — ranked #17 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹349.69 (as of 2026-11-13)
AUM₹1,430 Cr
Expense ratio1.83%
RiskometerVery High
Fund managerKamal Gada
Exit load1% for redemption within 30 days

Performance & risk

5-year annualised return14.93%
Sharpe ratio1.01
Standard deviation15.99%
Max drawdown−33.91%
Alpha-0.05
Beta0.96

Over 5 years, captured 92.6% of NIFTY Pharma's upside and 88.2% of its downside.

Market cap allocation

Large cap19.6%
Mid cap36.0%
Small cap44.5%

Concentration

Top 5 holdings28.2%
Top 10 holdings46.6%
Total holdings46

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)23.1%Q1 (Top)#8 of 76
2025−3.1%Q3#45 of 69
202442.9%Q1 (Top)#4 of 58
202338.2%Q2#21 of 48
2022−12.3%Q4 (Bottom)#40 of 46